Recent Comments
- Charles Carroll on Daily Alcohol is Not OK
- Charles Carroll on A food-borne illness mystery and what is wrong with current medical schools
- Is Italian flour healthier than American? | Quality of Life Clinic on Celiac disease is not reduced by breast feeding or delaying the introduction of gluten
- LB on The final House report on COVID
- Joy Smith on The Declaration of Pandemics
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (34,625)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (21,684)
- The Healthcare Channel hits 10 (19,337)
- New treatment paradigm for C. Diff colitis (18,015)
- How the FDA regulates compounding pharmacies (17,364)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (17,241)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (16,946)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (15,147)
- The new CDC guidelines for prescribing opioid pain pills (13,500)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (13,214)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Nutrition
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Otolaryngology
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: – Policy
Any type of coronavirus vaccine (i.e., gene therapy) that uses the spike-protein will be deadly
February 20, 2023- by Steven E. Greer, MD
Posted in - Biotech, - Opinion, - Pharma, FDA
Leave a comment
Interview with drug trials expert Sasha Latypova on how the COVID vaccine approvals were a sham
July 7, 2023- by Steven E. Greer, MD
Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, FDA, Infectious disease, NIH
Leave a comment
Paxlovid causes rebound COVID 25% of the time
January 7, 2024- by Steven E. Greer, MD
Posted in - Pharma, CDC, Emergency medicine, Infectious disease
Leave a comment
The slippery slope of stifling free speech
December 10, 2023- by Steven E. Greer, MD
Posted in - Opinion, - Policy
Leave a comment
Oral arguments in Cortex Television v. New York State Dept Health, Index No. 318612 (Sup. Ct., Albany Cnty. 2022)
October 18, 2023
Posted in - Policy
Leave a comment
Book: The Pfizer/Moderna mRNA Vaccine (i.e., gene therapy) Toxicity
September 1, 2023- by Sucharit Bhakdi, MD et al
Tony’s Virus
October 15, 2020- by Steven E. Greer, MD
Ivermectin works against COVID in double blind, randomized, controlled trial
May 2, 2023- by Steven E. Greer, MD A new medical meeting poster shows the results of a double blind, randomized, controlled trial of ivermectin as a therapy for COVID. The drug works very well.
Did the COVID vaccines change the human genome?
May 11, 2023- by Steven E. Greer, MD I was the first person on any large media platform to warn that the COVID vaccines would be hard to sell because they worked by altering our genes. I said this on … Continue reading
Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology
Leave a comment
Federal appeals court rules that our federal government violated the First Amendment during the pandemic
September 8, 2023- by Steven Greer (pro se litigator extraordinaire)
FDA CDER Director on Benlysta for lupus and adaptive clinical trials.
July 27, 2011- Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer,
Posted in - Biotech, - Pharma, FDA, Rheumatology
Leave a comment
The FDA pathway for biosimilar drug approvals
March 26, 2015- Interviewed by Steven E. Greer,
Posted in - Biotech, - Generics, FDA
Leave a comment
WABC radio morning show Bernie & Sid interviews Steven E. Greer, MD: May 21, 2020
May 21, 2020- by Steven E. Greer, MD In this segment,
I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show
March 23, 2020- I updated Joe Piscopo today, focusing on the new drugs to treat coronavirus.
Posted in - Opinion, - Policy, CDC, Congress, Emergency medicine, Infectious disease, NIH
Leave a comment
New treatment paradigm for C. Diff colitis
March 31, 2010- Produced and interviewed by Steven E. Greer, MD New drugs
Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs
October 24, 2010- Gordon Guyatt, MD, epidemiologist, internist, and biostatistician at McMaster
Posted in Cardiology, FDA, McMaster University
Leave a comment
Why are suicide rates increasing along with increased usage of antidepressants?
June 8, 2018- Fox News’ Tucker Carlson interviewed author Johan Hari about his book Lost Connections and the
Posted in - Pharma, - Policy, CDC, FDA, Neurology, Primary care medicine, Psychology Psychiatry
Leave a comment
Senator Angus King discusses his bill to make medical device pricing transparent to the public
July 9, 2014- Interviewed by Steven E. Greer, MD Senator Angus King from Maine has proposed a a bill that would make the pricing of medical devices
Posted in - Medical Devices, - Policy, Congress
Leave a comment